Articles On Imugene (ASX:IMU)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Zero Safety Issues for IMU’s Immunotherapy Cancer Treatment: Phase II Trial Imminent
Imugene (ASX:IMU) is a clinical stage life sciences company on the cutting edge of this very field and is developing vaccines to boost and direct the immune system to target and attack cancer cells. |
NextBiotech | IMU | 6 years ago |